CClinicalTrials.gg
Status unknownNCT021795933S/2S_SARPEUpdated Mar 16, 2016

Effectiveness of SARPE With 3 and 2-Segment Technique: A Randomized Clinical Trial

An interventional study of 2-Segment SARPE and 3-Segment SARPE in Maxillary Hypoplasia, sponsored by Federal University of São Paulo. Status unknown at 1 site in Brazil. Open to participants aged 17 Years to 50 Years. Per ClinicalTrials.gov, last updated 2016-03-16.

Sponsored by Federal University of São Paulo · Not applicable and Interventional

The sponsor has not verified this record recently (last verified Mar 2016), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
17 Years to 50 Years
Sex
All
01

Study summary

A few studies state that 3-segment SARPE has the following advantages: a) higher level of expansion symmetry; b) higher level of stability of the expansion achieved; and c) faster bone healing. The investigators hypothesize that 2-segment SARPE is as effective as 3-segment SARPE concerning treatment and/or quality of life in daily practice.

Read the detailed description

32 healthy, literate adult patients (male and female) with 7-millimeter transverse maxilla deficiency bilaterally distributed will participate in this study.

The participants will be assigned randomizable in equal number to undergo either 3-segment or 2-segment SARPE.

Individuals that a) have undergone maxilla surgery previously; b) have craniofacial anomaly;and c) have dental crowding will not be enrolled.

All participants will be assessed before and after surgery for sensitivity to pressure and temperature in the innervated structures linked to the maxilla, as well as for quality of life using OHIP-49 and B-OQLQ assessment tools.

The expansion of maxilla will be assessed by superimposing tomographic images before and after surgery.

02

Conditions studied

  • Maxillary Hypoplasia

Keywords

  • Maxillary expansion
  • Orthognathic surgery
  • Symmetry
  • Palatal expansion technique
  • Maxilla abnormality
03

In context

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being healthy and literate
  • Having 7-millimeter transverse maxilla deficiency bilaterally distributed.

Exclusion criteria

Exclusion Criteria:

  • Having undergone maxilla surgery previously
  • Having craniofacial anomaly
  • Having excessive dental crowding.
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Other
    2-Segment SARPE

    Maxilla expansion using one sagittal section of the maxilla.

    Other: 2-Segment SARPE

  • Other
    3-Segment SARPE

    Maxilla Expansion using two parasagittal section of the maxilla.

    Other: 3-Segment SARPE

Interventions

  • Other2-Segment SARPE

    Le Fort I osteotomy with oppening of the median palatal suture and SARPE.

    Also known as: Surgically Assisted Rapid Maxillary Expansion (SARME), Surgically Assisted Rapid Palatal Expansion (SARPE)

  • Other3-Segment SARPE

    Le Fort I osteotomy with two parallel osteotomies symetrically positioned with reference to the median palatal suture and SARPE.

    Also known as: Surgically Assisted Rapid Palatal Expansion (SARPE), Surgically Assisted Rapid MaxillaryExpansion (SARME)

06

What researchers measure

Primary outcomes

  1. Quality of Life

    The primary outcome chosen in this study is Quality of Life assessed through the Orthognathic Quality of Life Questionaire (OQLQ) and Oral Health Impact Profile (OHIP-49) currently available in Portuguese language and validated for scientific studies.

    Time frame: An average of 2 weeks after expansion.

Secondary outcomes

  1. Maxillary symmetry

    The maxillary symmetry will be assessed by analyzing before and after 3D imaging obtained from computed tomography data , superimposed using the Geomagic Qualify software.

    Time frame: pre-operative and an average of 2 weeks at the end of maxillary expansion.

  2. Stability of dental and osseous structures

    The stability of dental and osseous structures will be analyzed using computer-aided 3D analysis of data obtained through the scanning of dental casts using Bicam 3D scanner (Scaierman - Italy).

    Time frame: pre-operative, an average of 2 weeks at the end of the expansion, 4 months, 1 and 2 years after maxillary expansion.

  3. Nasal and paranasal topographic changes

    The nasal and paranasal topographic changes will be captured using laser scanner device.

    Time frame: pre-operative,an average of 2 weeks at the end of the expansion, 4 and 12 months after maxillary expansion.

07

Study locations

1 site
  • Federal University of Sao Paulo
    Sao Paulo, 04024002, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02179593
Lead sponsor
Federal University of São Paulo
Responsible party
Max Domingues Pereira (MD, PhD, Federal University of São Paulo) — Principal investigator
First posted
Jul 2, 2014
Start date
Sep 2013
Primary completion
Aug 2016 (estimated)
Completion
Dec 2016 (estimated)
Last update
Mar 16, 2016

Study contacts

Max D Pereira, PhD
principal investigator · Federal University of São Paulo
Gabriela PR Prado, MS
study chair · Federal University of São Paulo
Fabianne MG Furtado, PhD
study chair · Federal University of São Paulo
Lydia M Ferreira, PhD
study chair · Federal University of São Paulo

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion